BioCentury
ARTICLE | Company News

Deprenyl Animal Health Inc. deal

September 20, 1993 7:00 AM UTC

DAHI signed a letter of intent to negotiate with Hoechst Veterinar (Germany) for an exclusive license and supply agreement for DAHI's Anipryl l-deprenyl in selected European countries. Hoechst would be responsible for European regulatory approvals and marketing. Financial terms weren't disclosed. Anipryl is being developed to treat cognitive disorders in domestic animals. ...